2021 Investor Day
Strong balance sheet with ample liquidity
Summary balance sheet ($M, as of 6/30/2021)
Cash and cash equivalents
Total current assets
SA
Liquidity ($M, as of 6/30/2021)
Available credit
295
SA
1,600
$ 1,575
Cash
SA
295
Total assets
SA
$
4,728
Total available liquidity
$
1,895
Total current liabilities
$
912
Total debt
SA
655
Net debt
360
Total equity
$
2,886
.
●
Recent increase in inventory driven by supply chain risk mitigation, shift of products to new factory, and the launch of AirSense11
Working capital remains a focus
Debt levels remain modest; $1.6B available for drawdown under our existing revolver facility
Low leverage and strong liquidity provide financial flexibility
© 2021 ResMed | 2021 Investor Day - Sept 8, 2021
82View entire presentation